EP3545965
Nýstárleg peptíð og samsetning peptíða til notkunar í ónæmismeðferð gegn lifrarfrumukrabbameini (HCC) og öðrum krabbameinum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.12.2015EP published:
21.7.2021EP application number:
19170191.1
EP translation filed:
7.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
15.12.2035Expiry date:
15.12.2023
Title:
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
Timeline
Today
16.12.2015EP application
21.7.2021EP Publication
7.9.2021Translation submitted
15.10.2021Registration published
15.12.2023Expires
Owner
Name:
immatics Biotechnologies GmbHAddress:
Paul-Ehrlich-Straße 15, 72076 Tübingen, DE
Inventor
Name:
Weinschenk, ToniAddress:
73773 Aichwald, DE
Name:
Mahr, AndreaAddress:
72076 Tübingen, DE
Name:
Fritsche, JensAddress:
72144 Dusslingen, DE
Name:
Müller, PhillipAddress:
34117 Kassel, DE
Name:
Wiebe, AnitaAddress:
72124 Ruebgarten, DE
Name:
Missel, SarahAddress:
72072 Tübingen, DE
Agent
Name:
KIPA ABAddress:
Pósthólf 1065, Drottninggatan 11, SE
Priority
Number:
201423016Date:
23.12.2014Country:
GB
Number:
201462096165 PDate:
23.12.2014Country:
US
Number:
201501017Date:
21.1.2015Country:
GB
Classification
Categories:
A61K 38/04, C07K 7/00, C07K 7/06, C07K 7/08, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 16.12.2021
Expires: 15.12.2022
Payer: Patice ehf.
Number: 8
Paid: 22.12.2022
Expires: 15.12.2023
Payer: Árnason Faktor ehf.